Imen Sfar

823 total citations
80 papers, 628 citations indexed

About

Imen Sfar is a scholar working on Immunology, Rheumatology and Genetics. According to data from OpenAlex, Imen Sfar has authored 80 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Immunology, 19 papers in Rheumatology and 16 papers in Genetics. Recurrent topics in Imen Sfar's work include Systemic Lupus Erythematosus Research (12 papers), Renal Transplantation Outcomes and Treatments (11 papers) and Diabetes and associated disorders (11 papers). Imen Sfar is often cited by papers focused on Systemic Lupus Erythematosus Research (12 papers), Renal Transplantation Outcomes and Treatments (11 papers) and Diabetes and associated disorders (11 papers). Imen Sfar collaborates with scholars based in Tunisia, France and Poland. Imen Sfar's co-authors include Yousr Gorgi, T. Ben Abdallah, K. Ayed, R. Bardi, E. Abderrahim, L. Abdelmoula, M. Makhlouf, T. Ben Abdallah, R. Goucha and A. Chebil and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Annals of the Rheumatic Diseases.

In The Last Decade

Imen Sfar

74 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Imen Sfar Tunisia 16 251 134 124 111 110 80 628
Yousr Gorgi Tunisia 15 241 1.0× 117 0.9× 110 0.9× 97 0.9× 87 0.8× 66 564
José A. Campillo Spain 18 651 2.6× 133 1.0× 130 1.0× 94 0.8× 76 0.7× 80 1.0k
M.L. Sánchez Alegre United States 12 322 1.3× 75 0.6× 105 0.8× 75 0.7× 17 0.2× 28 654
AW Lohse Germany 11 301 1.2× 329 2.5× 103 0.8× 48 0.4× 379 3.4× 70 859
Monica Arenas United Kingdom 11 96 0.4× 138 1.0× 216 1.7× 141 1.3× 113 1.0× 19 874
Toshihiko Kaneshige Japan 17 411 1.6× 201 1.5× 95 0.8× 135 1.2× 203 1.8× 37 1.0k
Daniel Zecher Germany 15 616 2.5× 85 0.6× 215 1.7× 33 0.3× 40 0.4× 30 1.0k
Eliot Heher United States 12 244 1.0× 94 0.7× 185 1.5× 19 0.2× 81 0.7× 21 863
Catherine Edwards-Smith Australia 7 284 1.1× 391 2.9× 83 0.7× 40 0.4× 422 3.8× 10 832
Chen‐Chung Chu Taiwan 18 288 1.1× 140 1.0× 134 1.1× 193 1.7× 38 0.3× 30 685

Countries citing papers authored by Imen Sfar

Since Specialization
Citations

This map shows the geographic impact of Imen Sfar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imen Sfar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imen Sfar more than expected).

Fields of papers citing papers by Imen Sfar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Imen Sfar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imen Sfar. The network helps show where Imen Sfar may publish in the future.

Co-authorship network of co-authors of Imen Sfar

This figure shows the co-authorship network connecting the top 25 collaborators of Imen Sfar. A scholar is included among the top collaborators of Imen Sfar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Imen Sfar. Imen Sfar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abdallah, T. Ben, et al.. (2025). Association of HLA-DR, HLA-DQ, and HLA-B alleles with inclusion body myositis risk: A systematic review, a meta-analysis, a meta-regression and a trial sequential analysis. International Journal of Immunopathology and Pharmacology. 39. 1220541843–1220541843. 1 indexed citations
2.
Abdallah, T. Ben, et al.. (2024). Association of HLA class II alleles and haplotypes with bullous and mucus membrane pemphigoid risk: A systematic review, a meta-analysis and a meta-regression. International Journal of Immunopathology and Pharmacology. 38. 1210516999–1210516999.
3.
Abdelmoula, L., et al.. (2024). A regression predictive model for QuantiFERON-TB Gold Plus® indeterminate results in immunosuppressed patients. SAGE Open Medicine. 12. 3932129932–3932129932. 2 indexed citations
4.
Mahmoud, I., R. Tekaya, O. Saidane, et al.. (2023). Impact of FCGR2A R131H, FCGR3A F158V and FCGR3B NA1/NA2 polymorphisms on response to Fc-containing TNF inhibitors in Tunisian rheumatoid arthritis patients. Drug Metabolism and Personalized Therapy. 38(2). 155–162. 1 indexed citations
5.
Sfar, Imen, et al.. (2022). Comparative study of six SARS-CoV-2 serology assays: Diagnostic performance and antibody dynamics in a cohort of hospitalized patients for moderate to critical COVID-19. International Journal of Immunopathology and Pharmacology. 36. 3938543824–3938543824. 8 indexed citations
6.
Sfar, Imen, et al.. (2019). Association of Autoantibody to Rods and Rings with Hepatitis C Outcome and Viral Load. Viral Immunology. 32(5). 214–220. 6 indexed citations
7.
Sfar, Imen, Tahar Gargah, R. Bardi, et al.. (2018). Impact of Interleukin-17F Gene Polymorphisms in Outcome of Kidney Transplantation in Tunisian Recipients. Transplantation Proceedings. 50(1). 110–114. 2 indexed citations
8.
Sfar, Imen, et al.. (2015). Natural evolution of hepatitis C virus infection in hemodialysis Tunisian patients and CTLA-4 SNP's. World Journal of Gastroenterology. 21(35). 10150–10158. 1 indexed citations
9.
Gorgi, Yousr, Lamjed Bouslama, Imen Sfar, et al.. (2013). Phylogenetic Analysis of Isolated HCV Strains from Tunisian Hemodialysis Patients. Viral Immunology. 26(1). 40–48. 9 indexed citations
10.
Sfar, Imen, R. Bardi, T. Ben Abdallah, et al.. (2011). CD86 +1057G>A polymorphism and susceptibility to acute kidney allograft rejection.. PubMed. 5(3). 187–93. 11 indexed citations
11.
Sfar, Imen, M. Makhlouf, R. Bardi, et al.. (2011). Allograft renal rejection and chemokine polymorphism.. PubMed. 22(1). 18–23. 4 indexed citations
12.
Sfar, Imen. (2010). Lymphoid tyrosine phosphatase R620W variant and inflammatory bowel disease in Tunisia. World Journal of Gastroenterology. 16(4). 479–479. 6 indexed citations
13.
14.
Gorgi, Yousr, Imen Sfar, R. Goucha, et al.. (2010). [IL1/IL1 Ra, CTLA-4 and Apo1/Fas genes polymorphisms and susceptibility to IgA nephropathy in Tunisian patients].. PubMed. 88(11). 789–93. 8 indexed citations
15.
Sfar, Imen, Hassen Hadj Kacem, R. Bardi, et al.. (2010). (AT) Repeat in the 3′ Untranslated Region of the CTLA-4 Gene and Susceptibility to Acute Allograft Rejection in Tunisian Renal Transplantation. Transplantation Proceedings. 42(10). 4314–4317. 7 indexed citations
16.
Hamida, F. Ben, E. Abderrahim, A. Kheder, et al.. (2010). Short- and Long-Term Outcomes of Living Donors in Tunisia: A Retrospective Study. Transplantation Proceedings. 42(10). 4311–4313. 3 indexed citations
17.
Sfar, Imen, Samira Matri, Azza Filali, et al.. (2009). Polymorphism in ICAM-1, PECAM-1, E-selectin, and L-selectin genes in Tunisian patients with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology. 21(2). 167–175. 19 indexed citations
18.
Sfar, Imen, et al.. (2007). Clearance and Persistence of Hepatitis C Virus in a Tunisian Population: Association with HLA Class I and Class II. Viral Immunology. 20(2). 312–319. 27 indexed citations
19.
Sfar, Imen, et al.. (2007). Role of immune system, apoptosis and angiogenesis in pathogenesis of rheumatoid arthritis and joint destruction, a systematic review.. PubMed. 85(12). 991–8. 24 indexed citations
20.
Gorgi, Yousr, Imen Sfar, T. Ben Abdallah, et al.. (2006). CTLA-4 Exon 1 (+49) and Promoter (−318) Gene Polymorphisms in Kidney Transplantation. Transplantation Proceedings. 38(7). 2303–2305. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yousr Gorgi Breakdown of academic impact, for papers by José A. Campillo Breakdown of academic impact, for papers by M.L. Sánchez Alegre Breakdown of academic impact, for papers by AW Lohse Breakdown of academic impact, for papers by Monica Arenas Breakdown of academic impact, for papers by Toshihiko Kaneshige Breakdown of academic impact, for papers by Daniel Zecher Breakdown of academic impact, for papers by Eliot Heher Breakdown of academic impact, for papers by Catherine Edwards-Smith Breakdown of academic impact, for papers by Chen‐Chung Chu
Rankless by CCL
2026